Efficacy and safety of neoadjuvant S-1-based chemoradiotherapy in resectable and borderline-resectable pancreatic cancer: a long-term follow-up study

Abstract Background/objectives This study aimed to evaluate the safety, efficacy, and long-term outcomes of S-1-based neoadjuvant chemoradiotherapy (NACRT) in patients with resectable or borderline-resectable pancreatic ductal adenocarcinoma (PDAC). Methods This retrospective study included patients...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Gaku Shimane, Minoru Kitago, Yutaka Endo, Koichi Aiura, Hiroshi Yagi, Yuta Abe, Yasushi Hasegawa, Shutaro Hori, Masayuki Tanaka, Yutaka Nakano, Junichi Fukada, Yohei Masugi, Yuko Kitagawa
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2024-12-01
coleção:	World Journal of Surgical Oncology
Assuntos:	S-1-based neoadjuvant chemoradiotherapy Pancreatic ductal adenocarcinoma Resection Retrospective study
Acesso em linha:	https://doi.org/10.1186/s12957-024-03609-w
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!